Toxicity assessment of 7 anticancer compounds in zebrafish

International Journal of Toxicology

Volumn 33, Issue 2, 2014, Pages 98-105

  Gao, Xiao Ping ^a   Feng, Feng ^b   Zhang, Xiao Qi ^c   Liu, Xiao Xin ^a   Wang, Yu Bin ^a   She, Jin Xiong ^a,d   He, Zhi Heng ^e   He, Ming Fang ^a  

^a NANJING TECH UNIVERSITY   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

^c JINAN UNIVERSITY   (China)

^d MEDICAL COLLEGE OF GEORGIA   (United States)

^e HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

acute toxicity; anticancer compounds; cardiovascular toxicity; developmental toxicity; zebrafish

Indexed keywords

ANTINEOPLASTIC AGENT; AURANOFIN; CURCUMIN; GAMBOGIC ACID; MYCOPHENOLIC ACID; PACLITAXEL; THALIDOMIDE; TRIPTOLIDE;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING; BLOOD FLOW; BODY BUILD; BRADYCARDIA; CIRCULATION; DEVELOPMENTAL TOXICITY; DISEASE SEVERITY; EDEMA; EMBRYO; FIN (ORGAN); GROWTH DISORDER; HEART RATE; HEART RHYTHM; LC 50; LETHALITY; NONHUMAN; PERICARDIAL DISEASE; PERICARDIUM EDEMA; PHENOTYPE; PIGMENTATION; TOXICITY TESTING; YOLK SAC; ZEBRA FISH;

ACUTE TOXICITY; ANTICANCER COMPOUNDS; CARDIOVASCULAR TOXICITY; DEVELOPMENTAL TOXICITY; ZEBRAFISH;

ANIMALS; ANTINEOPLASTIC AGENTS; CARDIOVASCULAR DISEASES; EMBRYO, NONMAMMALIAN; EMBRYONIC DEVELOPMENT; HEMODYNAMICS; LARVA; LETHAL DOSE 50; TERATOGENS; ZEBRAFISH;

EID: 84898943429     PISSN: 10915818     EISSN: 1092874X     Source Type: Journal    
DOI: 10.1177/1091581814523142     Document Type: Article

References (43)

1. Eimon PM, Rubinstein AL. The use of in vivo zebrafish assays in drug toxicity screening. Expert Opin Drug Metab Toxicol. 2009 ; 5 (4). 393-401
2. Curigliano G, Mayer EL, Burstein HJ, Winer EP, Goldhirsch A. Cardiac toxicity from systemic cancer therapy: a comprehensive review. Prog Cardiovasc Dis. 2010 ; 53 (2). 94-104
3. Dasanu CA, Padmanabhan P, Clark BA III, Do C. Cardiovascular toxicity associated with small molecule tyrosine kinase inhibitors currently in clinical use. Expert Opin Drug Saf. 2012 ; 11 (3). 445-457
4. Marmiroli P, Nicolini G, Miloso M, Scuteri A, Cavaletti G. The fundamental role of morphology in experimental neurotoxicology: the example of chemotherapy-induced peripheral neurotoxicity. Ital J Anat Embryol. 2012 ; 117 (2). 75-97
5. Torino F, Barnabei A, De Vecchis L, et al. Chemotherapy-induced ovarian toxicity in patients affected by endocrine-responsive early breast cancer. Crit Rev Oncol Hematol. 2014 ; 89 (1). 27-42
6. Tamaki C, Nagayama T, Hashiba M, et al. Potentials and limitations of nonclinical safety assessment for predicting clinical adverse drug reactions: correlation analysis of 142 approved drugs in Japan. J Toxicol Sci. 2013 ; 38 (4). 581-598
7. Zhu JJ, Xu YQ, He JH, et al. Human cardiotoxic drugs delivered by soaking and microinjection induce cardiovascular toxicity in zebrafish. J Appl Ttoxicol. 2014 ; 34 (2). 139-148
8. Goldsmith P. Zebrafish as a pharmacological tool: the how, why and when. Curr Opin Pharmacol. 2004 ; 4 (5). 504-512
9. McGrath P, Li CQ. Zebrafish: a predictive model for assessing drug-induced toxicity. Drug Discov Today. 2008 ; 13 (9-10). 394-401
10. Wan B, Hu X, Nie J, et al. Effects of triptolide on degeneration of dendritic spines induced by Abeta injection in rat hippocampus. Neurol Sci. 2014 ; 35 (1). 35-40
11. Xu L, Chen H, Xu H, Yang X. Anti-tumour and immuno-modulation effects of triptolide-loaded polymeric micelles. Eur J Pharm Biopharm. 2008 ; 70 (3). 741-748
12. Liu Q. Triptolide and its expanding multiple pharmacological functions. Int Immunopharmacol. 2011 ; 11 (3). 377-383
13. Wang C, Zhang H, Chen B, Yin H, Wang W. Study of the enhanced anticancer efficacy of gambogic acid on Capan-1 pancreatic cancer cells when mediated via magnetic Fe3O4 nanoparticles. Int J Nanomed. 2011 ; 6: 1929-1935
14. Li X, Liu S, Huang H, et al. Gambogic acid is a tissue-specific proteasome inhibitor in vitro and in vivo. Cell Rep. 2013 ; 3 (1). 211-222
15. Domhan S, Muschal S, Schwager C, et al. Molecular mechanisms of the antiangiogenic and antitumor effects of mycophenolic acid. Mol Cancer Ther. 2008 ; 7 (6). 1656-1668
16. Lin SS, Lai KC, Hsu SC, et al. Curcumin inhibits the migration and invasion of human A549 lung cancer cells through the inhibition of matrix metalloproteinase-2 and -9 and vascular endothelial growth factor (VEGF). Cancer Lett. 2009 ; 285 (2). 127-133
17. Gandin V, Fernandes AP, Rigobello MP, et al. Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase. Biochem Pharmacol. 2010 ; 79 (2). 90-101
18. Lessa JA, Guerra JC, de Miranda LF, et al. Gold(I) complexes with thiosemicarbazones: cytotoxicity against human tumor cell lines and inhibition of thioredoxin reductase activity. J Inorg Biochem. 2011 ; 105 (12). 1729-1739
19. Mirabelli CK, Johnson RK, Sung CM, Faucette L, Muirhead K, Crooke ST. Evaluation of the in vivo antitumor activity and in vitro cytotoxic properties of auranofin, a coordinated gold compound, in murine tumor models. Cancer Res. 1985 ; 45 (1). 32-39
20. clinicaltrials.gov Identifier: NCT01419691 and clinicaltrials.gov Identifier: NCT01747798
21. Ito T, Ando H, Suzuki T, et al. Identification of a primary target of thalidomide teratogenicity. Science. 2010 ; 327 (5971). 1345-1350
22. Eichholz A, Merchant S, Gaya AM. Anti-angiogenesis therapies: their potential in cancer management. Onco Targets Ther. 2010 ; 3: 69-82
23. Ito T, Ando H, Handa H. Teratogenic effects of thalidomide: molecular mechanisms. Cell Mol Life Sci. 2011 ; 68 (9). 1569-1579
24. Nicolaou KC, Valiulin RA. Synthesis and biological evaluation of new paclitaxel analogs and discovery of potent antitumor agents. Org Biomol Chem. 2013 ; 11 (25). 4154-4163
25. Truong L, Harper SL, Tanguay RL. Evaluation of embryotoxicity using the zebrafish model. Methods Mol Biol. 2011 ; 691: 271-279
26. Mu X, Pang S, Sun X, et al. Evaluation of acute and developmental effects of difenoconazole via multiple stage zebrafish assays. Environ Pollut. 2013 ; 175: 147-157
27. Sukardi H, Chng HT, Chan EC, Gong Z, Lam SH. Zebrafish for drug toxicity screening: bridging the in vitro cell-based models and in vivo mammalian models. Expert Opin Drug Metab Toxicol. 2011 ; 7 (5). 579-589
28. Park JH, Chi SC, Lee WS, et al. Toxicity studies of cremophor-free paclitaxel solid dispersion formulated by a supercritical antisolvent process. Arch Pharm Res. 2009 ; 32 (1). 139-148
29. Guo Q, Qi Q, You Q, Gu H, Zhao L, Wu Z. Toxicological studies of gambogic acid and its potential targets in experimental animals. Basic Clin Pharmacol Toxicol. 2006 ; 99 (2). 178-184
30. Xu L, Qiu Y, Xu H, Ao W, Lam W, Yang X. Acute and subacute toxicity studies on triptolide and triptolide-loaded polymeric micelles following intravenous administration in rodents. Food Chem Toxicol. 2013 ; 57: 371-379
31. Sweeney MJ, Gerzon K, Harris PN, Holmes RE, Poore GA, Williams RH. Experimental antitumor activity and preclinical toxicology of mycophenolic acid. Cancer Res. 1972 ; 32 (9). 1795-1802
32. Li Q, Yang Y, Li X, Chen MF, Zheng SS. Study on the acute oral toxicity and genetic toxicity of curcumin. Chin J Health Lab Technol. 2011 ; 21 (7). 1707-1709
33. Letamendia A, Quevedo C, Ibarbia I, et al. Development and validation of an automated high-throughput system for zebrafish in vivo screenings. PLoS One. 2012 ; 7 (5). e36690
34. Sachidanandan C, Yeh JR, Peterson QP, Peterson RT. Identification of a novel retinoid by small molecule screening with zebrafish embryos. PLoS One. 2008 ; 3 (4). e1947
35. Sun HP, Liu ZL, Xue X, et al. Studies on chemical structure modification and structure-activity relationship of derivatives of gambogic acid at C(39). Chem Biodivers. 2012 ; 9 (8). 1579-1590
36. Huang W, He T, Chai C, et al. Triptolide inhibits the proliferation of prostate cancer cells and down-regulates SUMO-specific protease 1 expression. PLoS One. 2012 ; 7 (5). e37693
37. Liu K, Cang S, Ma Y, Chiao JW. Synergistic effect of paclitaxel and epigenetic agent phenethyl isothiocyanate on growth inhibition, cell cycle arrest and apoptosis in breast cancer cells. Cancer Cell Int. 2013 ; 13 (1). 10
38. Cai XZ, Huang WY, Qiao Y, et al. Inhibitory effects of curcumin on gastric cancer cells: a proteomic study of molecular targets. Phytomedicine. 2013 ; 20 (6). 495-505
39. Capitosti SM, Hansen TP, Brown ML. Thalidomide analogues demonstrate dual inhibition of both angiogenesis and prostate cancer. Bioorg Med Chem. 2004 ; 12 (2). 327-336
40. Eckardt K, Stahlmann R. Use of two validated in vitro tests to assess the embryotoxic potential of mycophenolic acid. Arch Toxicol. 2010 ; 84 (1). 37-43
41. Wu X, Zhong H, Song J, Damoiseaux R, Yang Z, Lin S. Mycophenolic acid is a potent inhibitor of angiogenesis. Arterioscler Thromb Vasc Biol. 2006 ; 26 (10). 2414-2416
42. Venardos K, Harrison G, Headrick J, Perkins A. Auranofin increases apoptosis and ischaemia-reperfusion injury in the rat isolated heart. Clin Exp Pharmacol Physiol. 2004 ; 31 (5-6). 289-294
43. Meyer T, Maier A, Borisow N, et al. Thalidomide causes sinus bradycardia in ALS. J Neurol. 2008 ; 255 (4). 587-591